Skip to main content
Erschienen in: Pediatric Radiology 5/2018

24.01.2018 | Original Article

Importance of whole-body imaging with complete coverage of hands and feet in alveolar rhabdomyosarcoma staging

verfasst von: Monika Scheer, Tobias Dantonello, Peter Brossart, Dagmar Dilloo, Lothar Schweigerer, Simone Feuchtgruber, Monika Sparber-Sauer, Christian Vokuhl, Stefan S. Bielack, Thomas Klingebiel, Ewa Koscielniak, Thekla von Kalle, on behalf of the Cooperative Weichteilsarkom Studiengruppe (CWS)

Erschienen in: Pediatric Radiology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Alveolar rhabdomyosarcoma commonly arises in the extremities and is characterized by aggressive biology and high frequency of metastases. Whole-body imaging is increasingly employed in pediatric oncology but not recommended as standard in the staging of soft-tissue sarcomas.

Objective

After observing patients with a large symptomatic alveolar rhabdomyosarcoma lesion and a smaller silent lesion in the more distal part of an extremity we sought to estimate the frequency of this constellation.

Materials and Methods

We retrospectively evaluated the data of prospectively registered paediatric patients (age <21 years) with alveolar rhabdomyosarcoma in the SoTiSaR (Soft Tissue Sarcoma Registry) of the Cooperative Weichteilsarkom Studiengruppe (CWS) 09/2011–04/2015 with regard to whole-body imaging.

Results

Seventy-five patients were eligible. Images of 57 patients had been submitted for reference consultation, including 80 whole-body examinations in 36 patients. Among them were 5 patients (14%, 95% confidence interval 3–25%) who had been diagnosed because of a symptomatic lesion while an additional silent lesion in the distal part of an extremity had remained unnoticed and had only been detected by later whole-body imaging. It is noteworthy that in 42 (53%) of all 80 whole-body examinations, the hands and feet had been only partially covered or completely excluded.

Conclusion

In alveolar rhabdomyosarcoma silent lesions can be overlooked when the distal parts of the limbs are not thoroughly examined and not completely covered by imaging. Missing them influences treatment decisions and prognosis. Our results should be considered when evaluating the potential role of whole-body imaging in rhabdomyosarcoma.
Literatur
1.
Zurück zum Zitat Klingebiel T, Boos J, Beske F et al (2008) Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatr Blood Cancer 50:739–745CrossRefPubMed Klingebiel T, Boos J, Beske F et al (2008) Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatr Blood Cancer 50:739–745CrossRefPubMed
2.
Zurück zum Zitat Scheer M, Dantonello T, Hallmen E et al (2016) Primary metastatic synovial sarcoma: experience of the CWS study group. Pediatr Blood Cancer 63:1198–1206CrossRefPubMed Scheer M, Dantonello T, Hallmen E et al (2016) Primary metastatic synovial sarcoma: experience of the CWS study group. Pediatr Blood Cancer 63:1198–1206CrossRefPubMed
3.
Zurück zum Zitat Oberlin O, Rey A, Lyden E et al (2008) Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 26:2384–2389CrossRefPubMedPubMedCentral Oberlin O, Rey A, Lyden E et al (2008) Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 26:2384–2389CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Weigel BJ, Lyden E, Anderson JR et al (2016) Intensive multiagent therapy, including dose-compressed cycles of ifosfamide/etoposide and vincristine/doxorubicin/cyclophosphamide, irinotecan, and radiation, in patients with high-risk rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol 34:117–122CrossRefPubMed Weigel BJ, Lyden E, Anderson JR et al (2016) Intensive multiagent therapy, including dose-compressed cycles of ifosfamide/etoposide and vincristine/doxorubicin/cyclophosphamide, irinotecan, and radiation, in patients with high-risk rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol 34:117–122CrossRefPubMed
5.
Zurück zum Zitat Scheer M, Dantonello T, Hallmen E et al (2016) Synovial sarcoma recurrence in children and young adults. Ann Surg Oncol 23:618–626CrossRefPubMed Scheer M, Dantonello T, Hallmen E et al (2016) Synovial sarcoma recurrence in children and young adults. Ann Surg Oncol 23:618–626CrossRefPubMed
6.
Zurück zum Zitat The ESMO/European Sarcoma Network Working Group (2014) Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25, Issue suppl_3, 1, iii102–iii112 The ESMO/European Sarcoma Network Working Group (2014) Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25, Issue suppl_3, 1, iii102–iii112
7.
Zurück zum Zitat Hays DM, Newton W Jr, Soule EH et al (1983) Mortality among children with rhabdomyosarcomas of the alveolar histologic subtype. J Pediatr Surg 18:412–417CrossRefPubMed Hays DM, Newton W Jr, Soule EH et al (1983) Mortality among children with rhabdomyosarcomas of the alveolar histologic subtype. J Pediatr Surg 18:412–417CrossRefPubMed
8.
Zurück zum Zitat Koscielniak E, Rodary C, Flamant F et al (1992) Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: a retrospective European multi-center analysis. Med Pediatr Oncol 20:209–214CrossRefPubMed Koscielniak E, Rodary C, Flamant F et al (1992) Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: a retrospective European multi-center analysis. Med Pediatr Oncol 20:209–214CrossRefPubMed
9.
10.
Zurück zum Zitat Casanova M, Meazza C, Favini F et al (2009) Rhabdomyosarcoma of the extremities: a focus on tumors arising in the hand and foot. Pediatr Hematol Oncol 26:321–331CrossRefPubMed Casanova M, Meazza C, Favini F et al (2009) Rhabdomyosarcoma of the extremities: a focus on tumors arising in the hand and foot. Pediatr Hematol Oncol 26:321–331CrossRefPubMed
11.
Zurück zum Zitat Miller DV, Coffin CM, Zhou H (2004) Rhabdomyosarcoma arising in the hand or foot: a clinicopathologic analysis. Pediatr Dev Pathol 7:361–369CrossRefPubMed Miller DV, Coffin CM, Zhou H (2004) Rhabdomyosarcoma arising in the hand or foot: a clinicopathologic analysis. Pediatr Dev Pathol 7:361–369CrossRefPubMed
12.
Zurück zum Zitat Harms D (1995) Alveolar rhabdomyosarcoma: a prognostically unfavorable rhabdomyosarcoma type and its necessary distinction from embryonal rhabdomyosarcoma. Curr Top Pathol 89:273–296CrossRefPubMed Harms D (1995) Alveolar rhabdomyosarcoma: a prognostically unfavorable rhabdomyosarcoma type and its necessary distinction from embryonal rhabdomyosarcoma. Curr Top Pathol 89:273–296CrossRefPubMed
13.
Zurück zum Zitat Ben Arush M, Minard-Colin V, Mosseri V et al (2015) Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma? Eur J Cancer 51:193–201CrossRefPubMed Ben Arush M, Minard-Colin V, Mosseri V et al (2015) Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma? Eur J Cancer 51:193–201CrossRefPubMed
15.
Zurück zum Zitat Sorensen PH, Lynch JC, Qualman SJ et al (2002) PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol 20:2672–2679CrossRefPubMed Sorensen PH, Lynch JC, Qualman SJ et al (2002) PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol 20:2672–2679CrossRefPubMed
16.
Zurück zum Zitat Armitage P, Berry G (ed) (1994) Inferences from proportions. In: Statistical methods in medical research, 3rd edn. Blackwell Scientific Publications, Oxford, pp 118–125 Armitage P, Berry G (ed) (1994) Inferences from proportions. In: Statistical methods in medical research, 3rd edn. Blackwell Scientific Publications, Oxford, pp 118–125
17.
Zurück zum Zitat Boellaard R, Delgado-Bolton R, Oyen WJ et al (2015) FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42:328–354CrossRefPubMed Boellaard R, Delgado-Bolton R, Oyen WJ et al (2015) FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42:328–354CrossRefPubMed
18.
Zurück zum Zitat Franzius C, Stauss J, Pfluger T et al (2010) Procedure guidelines for whole-body 18F-FDG PET and PET/CT in children with malignant diseases. Nuklearmedizin 49:225–233CrossRefPubMed Franzius C, Stauss J, Pfluger T et al (2010) Procedure guidelines for whole-body 18F-FDG PET and PET/CT in children with malignant diseases. Nuklearmedizin 49:225–233CrossRefPubMed
19.
Zurück zum Zitat Stauss J, Franzius C, Pfluger T et al (2008) Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging 35:1581–1588CrossRefPubMed Stauss J, Franzius C, Pfluger T et al (2008) Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging 35:1581–1588CrossRefPubMed
21.
Zurück zum Zitat Roberge D, Hickeson M, Charest M et al (2009) Utility of total body FDG PET/CT imaging in the initial staging of soft-tissue sarcoma. J Clin Oncol 27:10531 Roberge D, Hickeson M, Charest M et al (2009) Utility of total body FDG PET/CT imaging in the initial staging of soft-tissue sarcoma. J Clin Oncol 27:10531
22.
Zurück zum Zitat Eutsler EP, Khanna G (2016) Whole-body magnetic resonance imaging in children: technique and clinical applications. Pediatr Radiol 46:858–872CrossRefPubMed Eutsler EP, Khanna G (2016) Whole-body magnetic resonance imaging in children: technique and clinical applications. Pediatr Radiol 46:858–872CrossRefPubMed
23.
24.
Zurück zum Zitat Davis JT, Kwatra N, Schooler GR (2016) Pediatric whole-body MRI: a review of current imaging techniques and clinical applications. J Magn Reson Imaging 44:783–793CrossRefPubMed Davis JT, Kwatra N, Schooler GR (2016) Pediatric whole-body MRI: a review of current imaging techniques and clinical applications. J Magn Reson Imaging 44:783–793CrossRefPubMed
25.
Zurück zum Zitat Ponisio MR, McConathy J, Laforest R et al (2016) Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma. Pediatr Radiol 46:1258–1268CrossRefPubMedPubMedCentral Ponisio MR, McConathy J, Laforest R et al (2016) Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma. Pediatr Radiol 46:1258–1268CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Benusiglio PR, Brugieres L, Caron O (2016) Whole-Body MRI screening in children with Li-Fraumeni and other cancer predisposition syndromes. AJR Am J Roentgenol 206:W52CrossRefPubMed Benusiglio PR, Brugieres L, Caron O (2016) Whole-Body MRI screening in children with Li-Fraumeni and other cancer predisposition syndromes. AJR Am J Roentgenol 206:W52CrossRefPubMed
27.
Zurück zum Zitat Nievelstein RA, Littooij AS (2016) Whole-body MRI in paediatric oncology. Radiol Med 121:442–453CrossRefPubMed Nievelstein RA, Littooij AS (2016) Whole-body MRI in paediatric oncology. Radiol Med 121:442–453CrossRefPubMed
28.
Zurück zum Zitat Schafer JF, Gatidis S, Schmidt H et al (2014) Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Radiology 273:220–231CrossRefPubMed Schafer JF, Gatidis S, Schmidt H et al (2014) Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Radiology 273:220–231CrossRefPubMed
29.
Zurück zum Zitat Sher AC, Seghers V, Paldino MJ et al (2016) Assessment of sequential PET/MRI in comparison with PET/CT of pediatric lymphoma: a prospective study. AJR Am J Roentgenol 206:623–631CrossRefPubMed Sher AC, Seghers V, Paldino MJ et al (2016) Assessment of sequential PET/MRI in comparison with PET/CT of pediatric lymphoma: a prospective study. AJR Am J Roentgenol 206:623–631CrossRefPubMed
30.
Zurück zum Zitat Volker T, Denecke T, Steffen I et al (2007) Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 25:5435–5441CrossRefPubMed Volker T, Denecke T, Steffen I et al (2007) Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 25:5435–5441CrossRefPubMed
31.
Zurück zum Zitat Tateishi U, Hosono A, Makimoto A et al (2009) Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Ann Nucl Med 23:155–161CrossRefPubMed Tateishi U, Hosono A, Makimoto A et al (2009) Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Ann Nucl Med 23:155–161CrossRefPubMed
32.
Zurück zum Zitat Weihkopf T, Blettner M, Dantonello T et al (2008) Incidence and time trends of soft tissue sarcomas in German children 1985-2004 — a report from the population-based German Childhood Cancer Registry. Eur J Cancer 44:432–440CrossRefPubMed Weihkopf T, Blettner M, Dantonello T et al (2008) Incidence and time trends of soft tissue sarcomas in German children 1985-2004 — a report from the population-based German Childhood Cancer Registry. Eur J Cancer 44:432–440CrossRefPubMed
33.
Zurück zum Zitat Kuttesch JF Jr, Parham DM, Kaste SC et al (1995) Embryonal malignancies of unknown primary origin in children. Cancer 75:115–121CrossRefPubMed Kuttesch JF Jr, Parham DM, Kaste SC et al (1995) Embryonal malignancies of unknown primary origin in children. Cancer 75:115–121CrossRefPubMed
34.
Zurück zum Zitat Pappo AS, Shapiro DN, Crist WM et al (1995) Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 13:2123–2139CrossRefPubMed Pappo AS, Shapiro DN, Crist WM et al (1995) Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 13:2123–2139CrossRefPubMed
35.
Zurück zum Zitat Dantonello TM, Int-Veen C, Harms D et al (2009) Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. J Clin Oncol 27:1446–1455CrossRefPubMed Dantonello TM, Int-Veen C, Harms D et al (2009) Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. J Clin Oncol 27:1446–1455CrossRefPubMed
36.
Zurück zum Zitat Asmar L, Gehan EA, Newton WA et al (1994) Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classifications Cancer 74:2579–2588PubMed Asmar L, Gehan EA, Newton WA et al (1994) Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classifications Cancer 74:2579–2588PubMed
Metadaten
Titel
Importance of whole-body imaging with complete coverage of hands and feet in alveolar rhabdomyosarcoma staging
verfasst von
Monika Scheer
Tobias Dantonello
Peter Brossart
Dagmar Dilloo
Lothar Schweigerer
Simone Feuchtgruber
Monika Sparber-Sauer
Christian Vokuhl
Stefan S. Bielack
Thomas Klingebiel
Ewa Koscielniak
Thekla von Kalle
on behalf of the Cooperative Weichteilsarkom Studiengruppe (CWS)
Publikationsdatum
24.01.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 5/2018
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-017-4066-8

Weitere Artikel der Ausgabe 5/2018

Pediatric Radiology 5/2018 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.